Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Compounding Pharmacists Group Asks FDA To Reject Wyeth's Citizen Petition On Premarin

This article was originally published in The Pink Sheet Daily

Executive Summary

Supporters of Wyeth's petition have financial ties to the company, International Academy of Compounding Pharmacists says.

You may also be interested in...



Compounding Pharmacists Group Issues Uniform Labeling Guidelines

Guidelines are latest response to Wyeth’s claim that compounders are manufacturing copies of Premarin.

Compounding Pharmacists Group Issues Uniform Labeling Guidelines

Guidelines are latest response to Wyeth’s claim that compounders are manufacturing copies of Premarin.

FDA Compounding Policy To Have Day In Court In December

Ten pharmacies challenging the agency's compounding policy say the lawsuit is an effort to stop "FDA's end-run on the Western States decision," which threw out restrictions on advertising for compounding products.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061401

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel